000 | 01715 a2200481 4500 | ||
---|---|---|---|
005 | 20250517084604.0 | ||
264 | 0 | _c20161226 | |
008 | 201612s 0 0 eng d | ||
022 | _a1791-2423 | ||
024 | 7 |
_a10.3892/ijo.2016.3425 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPan, Yunbao | |
245 | 0 | 0 |
_aA novel curcuminoid exhibits enhanced antitumor activity in nasopharyngeal carcinoma. _h[electronic resource] |
260 |
_bInternational journal of oncology _cMay 2016 |
||
300 |
_a2175-83 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aActivating Transcription Factor 4 _xgenetics |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 | _aApoptosis |
650 | 0 | 4 | _aCarcinoma |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aCurcumin _xadministration & dosage |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEndoplasmic Reticulum Stress _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aNasopharyngeal Carcinoma |
650 | 0 | 4 |
_aNasopharyngeal Neoplasms _xdrug therapy |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTranscription Factor CHOP _xgenetics |
650 | 0 | 4 |
_aX-Box Binding Protein 1 _xmetabolism |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aLiu, Guohong | |
700 | 1 | _aXiao, Jian | |
700 | 1 | _aSu, Bojin | |
700 | 1 | _aZhou, Fuling | |
700 | 1 | _aWei, Yongchang | |
773 | 0 |
_tInternational journal of oncology _gvol. 48 _gno. 5 _gp. 2175-83 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3892/ijo.2016.3425 _zAvailable from publisher's website |
999 |
_c25833626 _d25833626 |